Cuál es el precio por Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Precio por Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) es de$1.15

Cuál es la capitalización de mercado por Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Capitalización de mercado por Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) es $88.79M

Ganancias de Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Año	Ganancias	Cambiar
Not enough data for the provided dates.

Año

Ganancias

Cambiar

Not enough data for the provided dates.

Empresa	Ganancias	Diferencia de ganancias	País
Royalty Pharma plc RPRX.US	$1.35B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$26.37M	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

Empresa

Ganancias

Diferencia de ganancias

País